HLA-C and neoplasm: Strategies of augmenting the host immune responses to the tumor included the introduction of genes encoding MHC molecules (7), co-stimulatory molecules (8) and cytokines (9) into tumor cells or DCs to improve immunogenicity and antigen-presenting capabilities.